Patrick Kaltenbach Sells 942 Shares of Mettler-Toledo International (NYSE:MTD) Stock

Mettler-Toledo International, Inc. (NYSE:MTD) CEO Patrick Kaltenbach sold 942 shares of Mettler-Toledo International stock in a transaction that occurred on Thursday, August 27th. The stock was sold at an average price of $1,425.00, for a total value of $1,342,350.00. Following the completion of the transaction, the chief executive officer owned 4,480 shares of the company’s stock, valued at approximately $6,384,000. The trade was a 17.37% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Mettler-Toledo International Stock Performance

MTD stock traded down $8.85 during midday trading on Monday, reaching $1,389.73. The company had a trading volume of 21,544 shares, compared to its average volume of 176,396. The firm has a market capitalization of $27.85 billion, a PE ratio of 31.34, a P/E/G ratio of 2.88 and a beta of 1.23. The stock has a 50 day moving average price of $1,345.25 and a 200 day moving average price of $1,274.28. Mettler-Toledo International, Inc. has a fifty-two week low of $1,023.05 and a fifty-two week high of $1,525.17. The company has a quick ratio of 0.78, a current ratio of 1.12 and a debt-to-equity ratio of 159.45.

Mettler-Toledo International (NYSE:MTD) last issued its earnings results on Friday, July 31st. The medical instruments supplier reported $11.46 earnings per share for the quarter, topping the consensus estimate of $10.78 by $0.68. The firm had revenue of $1.03 billion for the quarter, compared to analyst estimates of $1.03 billion. Mettler-Toledo International had a negative return on equity of 1,212.14% and a net margin of 21.91%.The firm’s revenue for the quarter was up 4.5% on a year-over-year basis. During the same period last year, the company earned $10.09 earnings per share. Analysts anticipate that Mettler-Toledo International, Inc. will post 47.35 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on MTD shares. Barclays upped their price objective on shares of Mettler-Toledo International from $1,300.00 to $1,575.00 and gave the stock an “overweight” rating in a report on Monday, August 3rd. Robert W. Baird dropped their price target on shares of Mettler-Toledo International from $1,445.00 to $1,194.00 and set a “neutral” rating on the stock in a research report on Monday, May 11th. Wall Street Zen lowered shares of Mettler-Toledo International from a “buy” rating to a “hold” rating in a research note on Saturday, May 16th. Jefferies Financial Group raised their price objective on shares of Mettler-Toledo International from $1,400.00 to $1,580.00 and gave the company a “buy” rating in a research note on Friday, July 31st. Finally, Citigroup dropped their target price on Mettler-Toledo International from $1,700.00 to $1,550.00 and set a “buy” rating on the stock in a report on Friday, May 8th. Six investment analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to MarketBeat, Mettler-Toledo International has an average rating of “Hold” and a consensus target price of $1,461.27.

Hedge Funds Weigh In On Mettler-Toledo International

Several large investors have recently made changes to their positions in MTD. XXEC Inc. acquired a new position in Mettler-Toledo International in the second quarter worth approximately $77,044,000. California State Teachers Retirement System boosted its stake in shares of Mettler-Toledo International by 114,807.7% during the 2nd quarter. California State Teachers Retirement System now owns 35,100,865 shares of the medical instruments supplier’s stock worth $44,841,706,000 after acquiring an additional 35,070,318 shares in the last quarter. BlackRock Inc. acquired a new position in shares of Mettler-Toledo International in the 2nd quarter worth $2,404,713,000. Capital International Investors raised its position in shares of Mettler-Toledo International by 12.7% during the fourth quarter. Capital International Investors now owns 969,067 shares of the medical instruments supplier’s stock worth $1,351,064,000 after purchasing an additional 109,508 shares during the period. Finally, T. Rowe Price Investment Management Inc. lifted its holdings in shares of Mettler-Toledo International by 0.5% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 691,565 shares of the medical instruments supplier’s stock valued at $964,174,000 after purchasing an additional 3,157 shares during the last quarter. Institutional investors own 95.07% of the company’s stock.

About Mettler-Toledo International

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.